C9orf72 and amyotrophic lateral sclerosis: Similarly, a longitudinal study investigating carriers of the C9orf72 hexanucleotide expansion might provide an indication as to how early TDP-43 aggregation occurs, and potentially would allow us to diagnose FTD-ALS spectrum disorders pre-symptomatically in these patients [4, 7, 21].